ES2059889T3 - Preparado liofilizado de 6-(3-dimetilaminopropionil)-forskolina. - Google Patents

Preparado liofilizado de 6-(3-dimetilaminopropionil)-forskolina.

Info

Publication number
ES2059889T3
ES2059889T3 ES90110942T ES90110942T ES2059889T3 ES 2059889 T3 ES2059889 T3 ES 2059889T3 ES 90110942 T ES90110942 T ES 90110942T ES 90110942 T ES90110942 T ES 90110942T ES 2059889 T3 ES2059889 T3 ES 2059889T3
Authority
ES
Spain
Prior art keywords
lyophilized preparation
dimethylaminopropionyl
forskolin
resolubility
sugar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90110942T
Other languages
English (en)
Inventor
Emiko Yamasaki
Takaaki Ohkuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Application granted granted Critical
Publication of ES2059889T3 publication Critical patent/ES2059889T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)

Abstract

UNA PREPARACION LIOFILIZADA QUE COMPRENDE FORSKOLIN(DIMETILAMINOPROPIONIL-3)-6, UN AGENTE AMORTIGUADOR QUE TIENE UN VALOR PH DE 3 A 6 CUANDO SE DISUELVE, Y, COMO INGREDIENTE OPCIONAL, UN AZUCAR. LA PREPARACION LIOFILIZADA ES EXCELENTE EN RESOLUBILIDAD Y ESTABLE EN AMBOS PH Y PORCENTAJE RESIDUAL.
ES90110942T 1989-06-15 1990-06-09 Preparado liofilizado de 6-(3-dimetilaminopropionil)-forskolina. Expired - Lifetime ES2059889T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15059589 1989-06-15

Publications (1)

Publication Number Publication Date
ES2059889T3 true ES2059889T3 (es) 1994-11-16

Family

ID=15500318

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90110942T Expired - Lifetime ES2059889T3 (es) 1989-06-15 1990-06-09 Preparado liofilizado de 6-(3-dimetilaminopropionil)-forskolina.

Country Status (13)

Country Link
US (1) US5051132A (es)
EP (1) EP0402805B1 (es)
JP (1) JPH06102625B2 (es)
KR (1) KR0138104B1 (es)
AU (1) AU625369B2 (es)
CA (1) CA2018573C (es)
CZ (1) CZ280278B6 (es)
DE (1) DE69003178T2 (es)
ES (1) ES2059889T3 (es)
HU (1) HU206619B (es)
PL (1) PL164449B1 (es)
RU (2) RU1836080C (es)
TW (1) TW199104B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5456234B2 (ja) 2003-06-30 2014-03-26 アルザ・コーポレーシヨン 非揮発性の対イオンを含有する被覆された微小突起のための製剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2149304A (en) * 1936-04-20 1939-03-07 Sharp & Dohme Inc Lyophilic biologically active substances
GB1357731A (en) * 1970-02-12 1974-06-26 Ethichem Ltd Free flowing powder compositions and ointments containing them'
US4517200A (en) * 1982-12-27 1985-05-14 Schering-Plough Corporation Method for treating allergic reactions with forskolin
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
EP0191166B1 (en) * 1984-12-14 1991-02-06 Hoechst-Roussel Pharmaceuticals Incorporated Aminoacyllabdanes, a process and intermediates for their preparation and their use as medicaments
EP0193132B1 (en) * 1985-03-01 1991-04-17 Hoechst-Roussel Pharmaceuticals Incorporated Labdan-derivatives, a process for their preparation and their use as medicaments
AU591196B2 (en) * 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
US4956391A (en) * 1988-08-17 1990-09-11 Sapse Alfred T Protected complex of procaine for the treatment of symptoms from narcotics addiction, tinnitus and alzheimer's disease
US4936074A (en) * 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament

Also Published As

Publication number Publication date
HU206619B (en) 1992-12-28
EP0402805B1 (en) 1993-09-08
JPH06102625B2 (ja) 1994-12-14
CS9002968A2 (en) 1991-11-12
TW199104B (es) 1993-02-01
HU903849D0 (en) 1990-11-28
EP0402805A1 (en) 1990-12-19
CZ280278B6 (cs) 1995-12-13
KR910000164A (ko) 1991-01-29
AU5700690A (en) 1990-12-20
DE69003178T2 (de) 1994-03-10
KR0138104B1 (ko) 1998-05-15
HUT59309A (en) 1992-05-28
RU2095061C1 (ru) 1997-11-10
DE69003178D1 (de) 1993-10-14
PL285504A1 (en) 1991-02-11
US5051132A (en) 1991-09-24
JPH0386820A (ja) 1991-04-11
CA2018573A1 (en) 1990-12-15
AU625369B2 (en) 1992-07-09
PL164449B1 (en) 1994-07-29
CA2018573C (en) 1998-12-01
RU1836080C (ru) 1993-08-23

Similar Documents

Publication Publication Date Title
PL315941A1 (en) 4-heterocyclic substituted derivatives of quinazoline, methods of obtaining them and their application as anticarcinogenic agents
TNSN92004A1 (fr) Derive de la 5h-pyrrolo (3,4-b) pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent
EP0386757A3 (en) Biodegradable poly (phosphate esters)
GB2197329B (en) Hard tissue substitute composition
NZ212051A (en) Immune response suppression; certain epipolythio- dioxopiperazine derivatives and their preparation
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
DE69431162D1 (en) Fenbendazolformulierungen
IT8720260A0 (it) Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti.
IL74727A (en) Derivatives of hydroxy-4-2h-1-benzothiopyran-2-one,their preparation and their use as rodenticides
ZA902627B (en) Substituted 1,8-naphthyridines
ES2059889T3 (es) Preparado liofilizado de 6-(3-dimetilaminopropionil)-forskolina.
ITMI920710A0 (it) Siringa di sicurezza con ago retrattile dopo l'uso in modo da evitare il riutilizzo della siringa e la diffusione di malattie contagiose per punture accidentali dell'ago.
AU7544787A (en) Synthetic alkali metal alumino-silicates, methods and uses, compositions and their methods of preparation
GB8406544D0 (en) Pyrethroid compositions
HUT48096A (en) Insecticides comprising 2-imino-1,3-dithiethane derivatives as active ingredient and process for producing the active ingredients
IL86970A0 (en) Ascorbic acid derivative,its preparation and its use as antioxidant
IT8919524A0 (it) Derivati dal 1 arilsolfonil 2 piperidone, loro procedimento di preparazione e loro impiego come farmaci.
IL93791A0 (en) Substituted biphenyls,their preparation and medicaments comprising them
IL88393A0 (en) Imidiates,their preparation and their use as insecticides
ES2029462T3 (es) Empleo de 2-terc.-butil-4-metil-ciclohexanol como perfumantes asi como a modo de componente de composiciones perfumantes.
EP0276204A3 (en) Pyridine gametocides
BR9006808A (pt) Carga vegetal porosa,micronizada,pouco densa,de granulometria controlada e de baixas superficies especificas fisica e hidraulica,processo de preparacao e utilizacao
IL85433A0 (en) Milbemycin derivatives,their preparation and their use as pesticides
SE9003181D0 (sv) Use of heparin fraction
EP0338756A3 (en) Use of 1,2,4-trioxanes as antiparasitics and anthelmintics

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 402805

Country of ref document: ES